Effect of Drug on Left Heart Remodeling after Transcatheter Closure of Patent Ductus Arteriosus with Domestic Occluder
WANG Xiaoyan,ZHOU Daxin,HUANG Guoqian,ZHANG Feng,GE Junbo
DOI: https://doi.org/10.3969/j.issn.1001-1439.2007.05.003
2007-01-01
Journal of Clinical Cardiology
Abstract:Objective:To assess the regular change of cardiac form and function after transcatheter closure of patent ductus arteriosus with domestic occluder, the effect of perindopril on left cardiac remodelling and pulmonary hypertension.Method:Twenty patients whose sizes of PDA were more than 5mm, and age were older than seventeen years, were divided into treatment group and control group according to identical sex and age±5 years, two groups were regularly given Aspirin in the day before operation, 200 mg·d-1×1 moth, then 100 mg·d-1×5 moths, treatment group was also given perindopril 2 mg·d-1×6 moths. Echocardiographic and electrocardiographic examinations were performed before and after closure of PDA, cardiac volume and ejection fraction was measured by area-length method, pulmonary systolic pressure by continuous wave Doppler according to tricuspid reflow.Result:Fifteen patients without drug have no significant difference of right cardiac diameter,LVEF, FS between before and after closure (P0.05). The left cardiac diameter and volume, pulmonary diameter (PD), pulmonary systolic pressure (PSP) decreased significantly (P0.05) between before and 24 h or 3 months after intervention, whereas they had no significant difference between 6 months and 3 months after closure (P0.05). Left ventricular ejection fraction (LVEF) and left ventricular shorten fraction (FS) showed no significant difference during the follow-up after closure compared with those before closure (P0.05). After 6 month therapy with perindopril, the improvement of left ventricular end-diastolic and end-systolic diameter, end-diastolic volume, LVEF, FS, PD, PSP were significantly different between two groups (P0.05), baseline of both groups had no significant difference (P0.05).Conclusion:With 6 month follow-up, Perindopril could decrease PSP and PD, improve left cardiac function, size and morphology significantly after the transcatheter closure of PDA, better clinical symptoms.